Kinetic analysis and comparison of uptake, distribution, and excretion of 48V-labeled compounds in rats

Setyawati, I. A., K. H. Thompson, V. G. Yuen, Y. Sun, M. Battell, D. M. Lyster, C. Vo, T. J. Ruth, S. Zeisler, J. H. McNeill, and C. Orvig. Kinetic analysis and comparison of uptake,distribution, and excretion of⁴⁸V-labeled compounds in rats.J. Appl. Physiol. 84(2): 569-575, 1998.Vanadium has been found to be orally active in lowering plasmaglucose levels; thus it provides a potential treatment for diabetesmellitus. Bis(maltolato)oxovanadium(IV) (BMOV) is a well-characterizedorganovanadium compound that has been shown in preliminarystudies to have a potentially useful absorption profile. Tissuedistributions of BMOV compared with those of vanadyl sulfate (VS) werestudied in Wistar rats by using⁴⁸V as a tracer. In this study,the compounds were administered in carrier-added forms by either oralgavage or intraperitoneal injection. Data analyzed by a compartmentalmodel, by using simulation, analysis, and modeling (i.e., SAAM II)software, showed a pattern of increased tissue uptake with use of⁴⁸V-BMOV compared with⁴⁸VS. The highest⁴⁸V concentrations at 24 h aftergavage were in bone, followed by kidney and liver. Most ingested⁴⁸V was eliminated unabsorbed byfecal excretion. On average, ⁴⁸Vconcentrations in bone, kidney, and liver 24 h after oraladministration of ⁴⁸V-BMOV weretwo to three times higher than those of⁴⁸VS, which is consistent with theincreased glucose-lowering potency of BMOV in acute glucose loweringcompared with VS.